MedPath

Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion

Not Applicable
Completed
Conditions
Neck Pain
Acute Pain
Interventions
Other: Biofreeze
Other: Placebo
Registration Number
NCT03157349
Lead Sponsor
Sport and Spine Rehab Clinical Research Foundation
Brief Summary

The purpose of this study to compare the effect of Biofreeze® versus a Placebo on neck pain, disability, fear avoidance, and range of motion prior to and following cervical manipulation over the course of one week among patients with acute neck pain.

Detailed Description

The purpose of this study to compare the effect of Biofreeze® versus a Placebo on neck pain, disability, fear avoidance, and range of motion prior to and following cervical manipulation over the course of one week among patients with acute neck pain. Methods: A convenience sample of 60 acute neck pain patients will be recruited at their initial appointment prior to any therapy being applied. Exclusionary criteria will include pregnancy, cancer, or a corticosteroid injection within the past 2 weeks. Additionally, anyone who has a history of neck surgery will be excluded. Patients will be recruited following their initial examination if they meet the inclusion criteria of pain for less than 2 weeks and be \>18 years of age. Eligible patients who agree to participate in the study will complete the informed consent, demographics information questionnaire (including pain medication usage), and paper and pencil instruments that assess their pain, neck disability, and fear avoidance. Cervical range of motion and posture will also be evaluated (T1). After completing the initial paperwork and assessment, patients will then be randomized into either the Placebo \[A\] (n=30) or Biofreeze® \[B\] (n=30) group. Both the patient and investigator will be blind to whether topical A or B is the active product. The Biofreeze® group will have Biofreeze® applied directly over the erector spinae muscles of the cervical spine. The Placebo group will have a placebo form of Biofreeze® applied directly over the erector spinae muscles of the cervical spine. After the respective intervention, both groups will wait 10 minutes after the in product is applied to their skin. At the conclusion of the 10 minutes they will again rate their pain (T2). Following the pain rating, all patients will receive a cervical manipulation. Within 5 minutes following the cervical manipulation, all patients will rate their level of pain (T3). Following completion of this rating of pain within 5 minutes following manipulation all subjects will be given the same at-home pain management program. This pain management program will involve applying either Biofreeze® or Placebo to their neck four times per day for the next week based on previous randomization schedule prior to cervical manipulation. All subjects will be instructed to apply the gel they have been assigned directly on top of the erector spinae and site of pain of neck, from inferior to superior to inferior. At one week (T4) patients will complete the paper and pencil instruments and cervical range of motion from the first visit. In addition, at home pain management compliance and pain medication will be documented on a daily basis for the entire week.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • neck pain for less than 2 weeks and >18 years of age
Exclusion Criteria
  • pregnancy, cancer, or a corticosteroid injection within the past 2 weeks. Additionally, anyone who has a history of neck surgery will be excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalBiofreezeThe experimental group will receive the active product (Biofreeze) over the course of 1 week.
PlaceboPlaceboThe placebo will use a product created to mimic the topical analgesic Biofreeze over the course of one week. All active ingredients have been removed.
Primary Outcome Measures
NameTimeMethod
Change in Numeric Pain Rating Scale (NPRS) at 1 weekBaseline (T1), 10 minutes after application (T2), immediately following manipulation [15 minutes after application] (T3), 1 week (T4)
Change in Neck Disability Index (NDI) at 1 weekBaseline (T1), 1 week (T4)
Change Cervical Range of Motion at 1 weekBaseline (T1), 1 week (T4)

Using FDA cleared DorsaVi sensor system to measure cervical flexion, extension, side bending, and rotation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sport and Spine Rehab

🇺🇸

Landover, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath